{
    "abstract": "Human immunodeficiency virus (HIV) is the cause of one of the most lethal pandemics in human history, although in recent years access to highly effective anti-retroviral therapy has provided new hope worldwide. Transmission of HIV by sexual contact, childbirth and injection drug use has been reduced, but 2 million are newly infected each year, and much of the transmission is from people who do not know their status. In addition to known methods, a preventive vaccine is needed to end the pandemic. The extraordinary mutability and genetic diversity of HIV is an enormous challenge, but vaccines are being designed for broad coverage. Computer-aided design of mosaic immunogens, incorporating many epitopes from the entire genome or from conserved regions aim to induce CD8+ T cells to kill virus-infected cells or inhibit virus replication, while trimeric envelope proteins or synthetic mimics aim to induce broadly reactive neutralizing antibodies similar to those cloned from some infected patients. Induction of more potent and durable responses may require new adjuvants or replicating chimeric vectors chimeras that bear HIV genes. Passive or genetic delivery of broadly neutralizing antibodies may provide broad protection and/or lead to insights for vaccine designers. Proof-of-concept trials in non-human primates and in one human efficacy trial have provided scientific clues for a vaccine that could provide broad and durable protection against HIV. The use of vaccines to destroy HIV reservoirs as part of therapy or cure is now also being explored.",
    "author_highlights": [
        {
            "endOffset": 17802,
            "sentence": "HIV is highly variable thus requiring broad immune responses for an effective vaccine.",
            "startOffset": 17716
        },
        {
            "endOffset": 17888,
            "sentence": "Without correlates of protection, there is still much to learn about immunity to HIV.",
            "startOffset": 17803
        },
        {
            "endOffset": 17969,
            "sentence": "HIV-specific CD8 + T cells and bNAbs are both difficult to induce with vaccines.",
            "startOffset": 17889
        },
        {
            "endOffset": 18053,
            "sentence": "Whether DNA, protein or viral vector, vaccine designs now emphasize broad coverage.",
            "startOffset": 17970
        }
    ],
    "bib_entries": {
        "bib0170": {
            "authors": [
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Gottlieb"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Schroff"
                },
                {
                    "first": "Howard M.",
                    "initial": "H.M.",
                    "last": "Schanker"
                },
                {
                    "first": "Joel D.",
                    "initial": "J.D.",
                    "last": "Weisman"
                },
                {
                    "first": "Peng Thim",
                    "initial": "P.T.",
                    "last": "Fan"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Wolf"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Saxon"
                }
            ],
            "doi": "10.1056/NEJM198112103052401",
            "firstpage": "1425",
            "issn": "00284793",
            "lastpage": "1431",
            "pub_year": 1981,
            "title": "Pneumocystis carinii Pneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men: Evidence of a New Acquired Cellular Immunodeficiency",
            "volume": "305"
        },
        "bib0175": {
            "authors": [
                {
                    "first": "Henry",
                    "initial": "H.",
                    "last": "Masur"
                },
                {
                    "first": "Mary Ann",
                    "initial": "M.A.",
                    "last": "Michelis"
                },
                {
                    "first": "Jeffrey B.",
                    "initial": "J.B.",
                    "last": "Greene"
                },
                {
                    "first": "Ida",
                    "initial": "I.",
                    "last": "Onorato"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Vande Stouwe"
                },
                {
                    "first": "Robert S.",
                    "initial": "R.S.",
                    "last": "Holzman"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Wormser"
                },
                {
                    "first": "Lee",
                    "initial": "L.",
                    "last": "Brettman"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Lange"
                },
                {
                    "first": "Henry W.",
                    "initial": "H.W.",
                    "last": "Murray"
                },
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Cunningham-Rundles"
                }
            ],
            "doi": "10.1056/NEJM198112103052402",
            "firstpage": "1431",
            "issn": "00284793",
            "lastpage": "1438",
            "pub_year": 1981,
            "title": "An Outbreak of Community-Acquired Pneumocystis carinii Pneumonia: Initial Manifestation of Cellular Immune Dysfunction",
            "volume": "305"
        },
        "bib0180": null,
        "bib0185": null,
        "bib0190": null,
        "bib0195": null,
        "bib0200": {
            "authors": [
                {
                    "first": "Myron S.",
                    "initial": "M.S.",
                    "last": "Cohen"
                },
                {
                    "first": "Marybeth",
                    "initial": "M.",
                    "last": "McCauley"
                },
                {
                    "first": "Theresa R.",
                    "initial": "T.R.",
                    "last": "Gamble"
                }
            ],
            "doi": "10.1097/COH.0b013e32834f5cf2",
            "firstpage": "99",
            "issn": "1746630X",
            "lastpage": "105",
            "pmid": "22227585",
            "pub_year": 2012,
            "title": "HIV treatment as prevention and HPTN 052",
            "volume": "7"
        },
        "bib0205": {
            "authors": [
                {
                    "first": "Thomas M.",
                    "initial": "T.M.",
                    "last": "Harmon"
                },
                {
                    "first": "Kevin A.",
                    "initial": "K.A.",
                    "last": "Fisher"
                },
                {
                    "first": "Margaret G.",
                    "initial": "M.G.",
                    "last": "McGlynn"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Stover"
                },
                {
                    "first": "Mitchell J.",
                    "initial": "M.J.",
                    "last": "Warren"
                },
                {
                    "first": "Yu",
                    "initial": "Y.",
                    "last": "Teng"
                },
                {
                    "first": "Arne",
                    "initial": "A.",
                    "last": "N\u00e4veke"
                }
            ],
            "doi": "10.1371/journal.pone.0146387",
            "issn": "19326203",
            "pmid": "26731116",
            "pub_year": 2016,
            "title": "Exploring the potential health impact and cost-effectiveness of AIDS vaccine within a comprehensive HIV/AIDS response in lowand middle-income countries",
            "volume": "11"
        },
        "bib0210": {
            "authors": [
                {
                    "first": "Bruce D.",
                    "initial": "B.D.",
                    "last": "Walker"
                },
                {
                    "first": "Xu G.",
                    "initial": "X.G.",
                    "last": "Yu"
                }
            ],
            "doi": "10.1038/nri3478",
            "firstpage": "487",
            "issn": "14741733",
            "lastpage": "498",
            "pmid": "23797064",
            "pub_year": 2013,
            "title": "Unravelling the mechanisms of durable control of HIV-1",
            "volume": "13"
        },
        "bib0215": {
            "authors": [
                {
                    "first": "Scott G.",
                    "initial": "S.G.",
                    "last": "Hansen"
                },
                {
                    "first": "Julia C.",
                    "initial": "J.C.",
                    "last": "Ford"
                },
                {
                    "first": "Matthew S.",
                    "initial": "M.S.",
                    "last": "Lewis"
                },
                {
                    "first": "Abigail B.",
                    "initial": "A.B.",
                    "last": "Ventura"
                },
                {
                    "first": "Colette M.",
                    "initial": "C.M.",
                    "last": "Hughes"
                },
                {
                    "first": "Lia",
                    "initial": "L.",
                    "last": "Coyne-Johnson"
                },
                {
                    "first": "Nathan",
                    "initial": "N.",
                    "last": "Whizin"
                },
                {
                    "first": "Kelli",
                    "initial": "K.",
                    "last": "Oswald"
                },
                {
                    "first": "Rebecca",
                    "initial": "R.",
                    "last": "Shoemaker"
                },
                {
                    "first": "Tonya",
                    "initial": "T.",
                    "last": "Swanson"
                },
                {
                    "first": "Alfred W.",
                    "initial": "A.W.",
                    "last": "Legasse"
                },
                {
                    "first": "Maria J.",
                    "initial": "M.J.",
                    "last": "Chiuchiolo"
                },
                {
                    "first": "Christopher L.",
                    "initial": "C.L.",
                    "last": "Parks"
                },
                {
                    "first": "Michael K.",
                    "initial": "M.K.",
                    "last": "Axthelm"
                },
                {
                    "first": "Jay A.",
                    "initial": "J.A.",
                    "last": "Nelson"
                },
                {
                    "first": "Michael A.",
                    "initial": "M.A.",
                    "last": "Jarvis"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Piatak"
                },
                {
                    "first": "Jeffrey D.",
                    "initial": "J.D.",
                    "last": "Lifson"
                },
                {
                    "first": "Louis J.",
                    "initial": "L.J.",
                    "last": "Picker"
                }
            ],
            "doi": "10.1038/nature10003",
            "firstpage": "523",
            "issn": "00280836",
            "lastpage": "527",
            "pmid": "21562493",
            "pub_year": 2011,
            "title": "Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine",
            "volume": "473"
        },
        "bib0220": {
            "authors": [
                {
                    "first": "Melissa D.",
                    "initial": "M.D.",
                    "last": "Simek"
                },
                {
                    "first": "Wasima",
                    "initial": "W.",
                    "last": "Rida"
                },
                {
                    "first": "Frances H.",
                    "initial": "F.H.",
                    "last": "Priddy"
                },
                {
                    "first": "Pham",
                    "initial": "P.",
                    "last": "Pung"
                },
                {
                    "first": "Emily",
                    "initial": "E.",
                    "last": "Carrow"
                },
                {
                    "first": "Dagna S.",
                    "initial": "D.S.",
                    "last": "Laufer"
                },
                {
                    "first": "Jennifer K.",
                    "initial": "J.K.",
                    "last": "Lehrman"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Boaz"
                },
                {
                    "first": "Tony",
                    "initial": "T.",
                    "last": "Tarragona-Fiol"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Miiro"
                },
                {
                    "first": "Josephine",
                    "initial": "J.",
                    "last": "Birungi"
                },
                {
                    "first": "Anton",
                    "initial": "A.",
                    "last": "Pozniak"
                },
                {
                    "first": "Dale A.",
                    "initial": "D.A.",
                    "last": "McPhee"
                },
                {
                    "first": "Olivier",
                    "initial": "O.",
                    "last": "Manigart"
                },
                {
                    "first": "Etienne",
                    "initial": "E.",
                    "last": "Karita"
                },
                {
                    "first": "Andr\u00e9",
                    "initial": "A.",
                    "last": "Inwoley"
                },
                {
                    "first": "Walter",
                    "initial": "W.",
                    "last": "Jaoko"
                },
                {
                    "first": "Jack",
                    "initial": "J.",
                    "last": "DeHovitz"
                },
                {
                    "first": "Linda Gail",
                    "initial": "L.G.",
                    "last": "Bekker"
                },
                {
                    "first": "Punnee",
                    "initial": "P.",
                    "last": "Pitisuttithum"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Paris"
                },
                {
                    "first": "Laura M.",
                    "initial": "L.M.",
                    "last": "Walker"
                },
                {
                    "first": "Pascal",
                    "initial": "P.",
                    "last": "Poignard"
                },
                {
                    "first": "Terri",
                    "initial": "T.",
                    "last": "Wrin"
                },
                {
                    "first": "Patricia E.",
                    "initial": "P.E.",
                    "last": "Fast"
                },
                {
                    "first": "Dennis R.",
                    "initial": "D.R.",
                    "last": "Burton"
                },
                {
                    "first": "Wayne C.",
                    "initial": "W.C.",
                    "last": "Koff"
                }
            ],
            "doi": "10.1128/JVI.00110-09",
            "firstpage": "7337",
            "issn": "0022538X",
            "lastpage": "7348",
            "pmid": "19439467",
            "pub_year": 2009,
            "title": "Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm",
            "volume": "83"
        },
        "bib0225": {
            "authors": [
                {
                    "first": "Dennis R.",
                    "initial": "D.R.",
                    "last": "Burton"
                },
                {
                    "first": "Rafi",
                    "initial": "R.",
                    "last": "Ahmed"
                },
                {
                    "first": "Dan H.",
                    "initial": "D.H.",
                    "last": "Barouch"
                },
                {
                    "first": "Salvatore T.",
                    "initial": "S.T.",
                    "last": "Butera"
                },
                {
                    "first": "Shane",
                    "initial": "S.",
                    "last": "Crotty"
                },
                {
                    "first": "Adam",
                    "initial": "A.",
                    "last": "Godzik"
                },
                {
                    "first": "Daniel E.",
                    "initial": "D.E.",
                    "last": "Kaufmann"
                },
                {
                    "first": "M. Juliana",
                    "initial": "M.J.",
                    "last": "McElrath"
                },
                {
                    "first": "Michel C.",
                    "initial": "M.C.",
                    "last": "Nussenzweig"
                },
                {
                    "first": "Bali",
                    "initial": "B.",
                    "last": "Pulendran"
                },
                {
                    "first": "Chris N.",
                    "initial": "C.N.",
                    "last": "Scanlan"
                },
                {
                    "first": "William R.",
                    "initial": "W.R.",
                    "last": "Schief"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Silvestri"
                },
                {
                    "first": "Hendrik",
                    "initial": "H.",
                    "last": "Streeck"
                },
                {
                    "first": "Bruce D.",
                    "initial": "B.D.",
                    "last": "Walker"
                },
                {
                    "first": "Laura M.",
                    "initial": "L.M.",
                    "last": "Walker"
                },
                {
                    "first": "Andrew B.",
                    "initial": "A.B.",
                    "last": "Ward"
                },
                {
                    "first": "Ian A.",
                    "initial": "I.A.",
                    "last": "Wilson"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Wyatt"
                }
            ],
            "doi": "10.1016/j.chom.2012.09.008",
            "firstpage": "396",
            "issn": "19313128",
            "lastpage": "407",
            "pmid": "23084910",
            "pub_year": 2012,
            "title": "A blueprint for HIV vaccine discovery",
            "volume": "12"
        },
        "bib0230": {
            "authors": [
                {
                    "first": "Marc P.",
                    "initial": "M.P.",
                    "last": "Girard"
                },
                {
                    "first": "Wayne C.",
                    "initial": "W.C.",
                    "last": "Koff"
                }
            ],
            "doi": "10.1016/B978-1-4557-0090-5.00054-9",
            "firstpage": "1097",
            "lastpage": "1121",
            "pub_year": 2012,
            "title": "Human immunodeficiency virus vaccines"
        },
        "bib0235": {
            "authors": [
                {
                    "first": "Brigitte",
                    "initial": "B.",
                    "last": "Autran"
                }
            ],
            "doi": "10.1002/eji.201545513",
            "firstpage": "3215",
            "issn": "00142980",
            "lastpage": "3221",
            "pmid": "26542079",
            "pub_year": 2015,
            "title": "Toward a cure for HIV-Seeking effective therapeutic vaccine strategies",
            "volume": "45"
        },
        "bib0240": {
            "authors": [
                {
                    "first": "Geetha H.",
                    "initial": "G.H.",
                    "last": "Mylvaganam"
                },
                {
                    "first": "Guido",
                    "initial": "G.",
                    "last": "Silvestri"
                },
                {
                    "first": "Rama Rao",
                    "initial": "R.R.",
                    "last": "Amara"
                }
            ],
            "doi": "10.1016/j.coi.2015.05.001",
            "firstpage": "1",
            "issn": "09527915",
            "lastpage": "8",
            "pmid": "25996629",
            "pub_year": 2015,
            "title": "HIV therapeutic vaccines: moving towards a functional cure",
            "volume": "35"
        },
        "bib0245": null,
        "bib0250": {
            "authors": [
                {
                    "first": "Torben",
                    "initial": "T.",
                    "last": "Schiffner"
                },
                {
                    "first": "Quentin J.",
                    "initial": "Q.J.",
                    "last": "Sattentau"
                },
                {
                    "first": "Lucy",
                    "initial": "L.",
                    "last": "Dorrell"
                }
            ],
            "doi": "10.1186/1742-4690-10-72",
            "issn": "17424690",
            "pmid": "23866844",
            "pub_year": 2013,
            "title": "Development of prophylactic vaccines against HIV-1",
            "volume": "10"
        },
        "bib0255": {
            "authors": [
                {
                    "first": "Scott M.",
                    "initial": "S.M.",
                    "last": "Hammer"
                },
                {
                    "first": "Magdalena E.",
                    "initial": "M.E.",
                    "last": "Sobieszczyk"
                },
                {
                    "first": "Holly",
                    "initial": "H.",
                    "last": "Janes"
                },
                {
                    "first": "Shelly T.",
                    "initial": "S.T.",
                    "last": "Karuna"
                },
                {
                    "first": "Mark J.",
                    "initial": "M.J.",
                    "last": "Mulligan"
                },
                {
                    "first": "Doug",
                    "initial": "D.",
                    "last": "Grove"
                },
                {
                    "first": "Beryl A.",
                    "initial": "B.A.",
                    "last": "Koblin"
                },
                {
                    "first": "Susan P.",
                    "initial": "S.P.",
                    "last": "Buchbinder"
                },
                {
                    "first": "Michael C.",
                    "initial": "M.C.",
                    "last": "Keefer"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Frahm"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Hural"
                },
                {
                    "first": "Chuka",
                    "initial": "C.",
                    "last": "Anude"
                },
                {
                    "first": "Barney S.",
                    "initial": "B.S.",
                    "last": "Graham"
                },
                {
                    "first": "Mary E.",
                    "initial": "M.E.",
                    "last": "Enama"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Adams"
                },
                {
                    "first": "Edwin",
                    "initial": "E.",
                    "last": "DeJesus"
                },
                {
                    "first": "Richard M.",
                    "initial": "R.M.",
                    "last": "Novak"
                },
                {
                    "first": "Ian",
                    "initial": "I.",
                    "last": "Frank"
                },
                {
                    "first": "Carter",
                    "initial": "C.",
                    "last": "Bentley"
                },
                {
                    "first": "Shelly",
                    "initial": "S.",
                    "last": "Ramirez"
                },
                {
                    "first": "Rong",
                    "initial": "R.",
                    "last": "Fu"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Koup"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Mascola"
                },
                {
                    "first": "Gary J.",
                    "initial": "G.J.",
                    "last": "Nabel"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Montefiori"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Kublin"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Juliana McElrath"
                },
                {
                    "first": "Lawrence",
                    "initial": "L.",
                    "last": "Corey"
                },
                {
                    "first": "Peter B.",
                    "initial": "P.B.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1056/NEJMoa1310566",
            "firstpage": "2083",
            "issn": "00284793",
            "lastpage": "2092",
            "pmid": "24099601",
            "pub_year": 2013,
            "title": "Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine",
            "volume": "369"
        },
        "bib0260": {
            "authors": [
                {
                    "first": "Genevieve G.",
                    "initial": "G.G.",
                    "last": "Fouda"
                },
                {
                    "first": "Coleen K.",
                    "initial": "C.K.",
                    "last": "Cunningham"
                },
                {
                    "first": "Sallie R.",
                    "initial": "S.R.",
                    "last": "Permar"
                }
            ],
            "doi": "10.1001/jama.2015.1382",
            "firstpage": "1513",
            "issn": "00987484",
            "lastpage": "1514",
            "pmid": "25898044",
            "pub_year": 2015,
            "title": "Infant HIV-1 vaccines supplementing strategies to reduce maternal-child transmission",
            "volume": "313"
        },
        "bib0265": {
            "authors": [
                {
                    "first": "Jeffrey T.",
                    "initial": "J.T.",
                    "last": "Safrit"
                }
            ],
            "doi": "10.2174/1566524033479898",
            "firstpage": "303",
            "issn": "15665240",
            "lastpage": "312",
            "pmid": "12699365",
            "pub_year": 2003,
            "title": "HIV vaccines in infants and children: Past trials, present plans and future perspectives",
            "volume": "3"
        },
        "bib0270": {
            "authors": [
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "O'Connell"
                },
                {
                    "first": "Jean Louis",
                    "initial": "J.L.",
                    "last": "Excler"
                }
            ],
            "firstpage": "450",
            "issn": "1570162X",
            "lastpage": "463",
            "pmid": "24033301",
            "pub_year": 2013,
            "title": "HIV vaccine efficacy and immune correlates of risk",
            "volume": "11"
        },
        "bib0275": {
            "authors": [
                {
                    "first": "Beatriz",
                    "initial": "B.",
                    "last": "Mothe"
                },
                {
                    "first": "Xintao",
                    "initial": "X.",
                    "last": "Hu"
                },
                {
                    "first": "Anuska",
                    "initial": "A.",
                    "last": "Llano"
                },
                {
                    "first": "Margherita",
                    "initial": "M.",
                    "last": "Rosati"
                },
                {
                    "first": "Alex",
                    "initial": "A.",
                    "last": "Olvera"
                },
                {
                    "first": "Viraj",
                    "initial": "V.",
                    "last": "Kulkarni"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Valentin"
                },
                {
                    "first": "Candido",
                    "initial": "C.",
                    "last": "Alicea"
                },
                {
                    "first": "Guy R.",
                    "initial": "G.R.",
                    "last": "Pilkington"
                },
                {
                    "first": "Niranjan Y.",
                    "initial": "N.Y.",
                    "last": "Sardesai"
                },
                {
                    "first": "Muntsa",
                    "initial": "M.",
                    "last": "Rocafort"
                },
                {
                    "first": "Manel",
                    "initial": "M.",
                    "last": "Crespo"
                },
                {
                    "first": "Jorge",
                    "initial": "J.",
                    "last": "Carrillo"
                },
                {
                    "first": "Andr\u00e9s",
                    "initial": "A.",
                    "last": "Marco"
                },
                {
                    "first": "James I.",
                    "initial": "J.I.",
                    "last": "Mullins"
                },
                {
                    "first": "Lucy",
                    "initial": "L.",
                    "last": "Dorrell"
                },
                {
                    "first": "Tom\u00e1\u0161",
                    "initial": "T.",
                    "last": "Hanke"
                },
                {
                    "first": "Bonaventura",
                    "initial": "B.",
                    "last": "Clotet"
                },
                {
                    "first": "George N.",
                    "initial": "G.N.",
                    "last": "Pavlakis"
                },
                {
                    "first": "Barbara K.",
                    "initial": "B.K.",
                    "last": "Felber"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Brander"
                }
            ],
            "doi": "10.1186/s12967-015-0392-5",
            "issn": "14795876",
            "pmid": "25879820",
            "pub_year": 2015,
            "title": "A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques",
            "volume": "13"
        },
        "bib0280": {
            "authors": [
                {
                    "first": "Scott G.",
                    "initial": "S.G.",
                    "last": "Hansen"
                },
                {
                    "first": "Jonah B.",
                    "initial": "J.B.",
                    "last": "Sacha"
                },
                {
                    "first": "Colette M.",
                    "initial": "C.M.",
                    "last": "Hughes"
                },
                {
                    "first": "Julia C.",
                    "initial": "J.C.",
                    "last": "Ford"
                },
                {
                    "first": "Benjamin J.",
                    "initial": "B.J.",
                    "last": "Burwitz"
                },
                {
                    "first": "Isabel",
                    "initial": "I.",
                    "last": "Scholz"
                },
                {
                    "first": "Roxanne M.",
                    "initial": "R.M.",
                    "last": "Gilbride"
                },
                {
                    "first": "Matthew S.",
                    "initial": "M.S.",
                    "last": "Lewis"
                },
                {
                    "first": "Awbrey N.",
                    "initial": "A.N.",
                    "last": "Gilliam"
                },
                {
                    "first": "Abigail B.",
                    "initial": "A.B.",
                    "last": "Ventura"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Malouli"
                },
                {
                    "first": "Guangwu",
                    "initial": "G.",
                    "last": "Xu"
                },
                {
                    "first": "Rebecca",
                    "initial": "R.",
                    "last": "Richards"
                },
                {
                    "first": "Nathan",
                    "initial": "N.",
                    "last": "Whizin"
                },
                {
                    "first": "Jason S.",
                    "initial": "J.S.",
                    "last": "Reed"
                },
                {
                    "first": "Katherine B.",
                    "initial": "K.B.",
                    "last": "Hammond"
                },
                {
                    "first": "Miranda",
                    "initial": "M.",
                    "last": "Fischer"
                },
                {
                    "first": "John M.",
                    "initial": "J.M.",
                    "last": "Turner"
                },
                {
                    "first": "Alfred W.",
                    "initial": "A.W.",
                    "last": "Legasse"
                },
                {
                    "first": "Michael K.",
                    "initial": "M.K.",
                    "last": "Axthelm"
                },
                {
                    "first": "Paul T.",
                    "initial": "P.T.",
                    "last": "Edlefsen"
                },
                {
                    "first": "Jay A.",
                    "initial": "J.A.",
                    "last": "Nelson"
                },
                {
                    "first": "Jeffrey D.",
                    "initial": "J.D.",
                    "last": "Lifson"
                },
                {
                    "first": "Klaus",
                    "initial": "K.",
                    "last": "Fr\u00fch"
                },
                {
                    "first": "Louis J.",
                    "initial": "L.J.",
                    "last": "Picker"
                }
            ],
            "doi": "10.1126/science.1237874",
            "issn": "00368075",
            "pmid": "23704576",
            "pub_year": 2013,
            "title": "Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms",
            "volume": "340"
        },
        "bib0285": {
            "authors": [
                {
                    "first": "Jean Louis",
                    "initial": "J.L.",
                    "last": "Excler"
                },
                {
                    "first": "Georgia D.",
                    "initial": "G.D.",
                    "last": "Tomaras"
                },
                {
                    "first": "Nina D.",
                    "initial": "N.D.",
                    "last": "Russell"
                }
            ],
            "doi": "10.1097/COH.0b013e3283632c26",
            "firstpage": "421",
            "issn": "1746630X",
            "lastpage": "431",
            "pub_year": 2013,
            "title": "Novel directions in HIV-1 vaccines revealed from clinical trials",
            "volume": "8"
        },
        "bib0290": {
            "authors": [
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Borthwick"
                },
                {
                    "first": "Tina",
                    "initial": "T.",
                    "last": "Ahmed"
                },
                {
                    "first": "Beatrice",
                    "initial": "B.",
                    "last": "Ondondo"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Hayes"
                },
                {
                    "first": "Annie",
                    "initial": "A.",
                    "last": "Rose"
                },
                {
                    "first": "Umar",
                    "initial": "U.",
                    "last": "Ebrahimsa"
                },
                {
                    "first": "Emma Jo",
                    "initial": "E.J.",
                    "last": "Hayton"
                },
                {
                    "first": "Antony",
                    "initial": "A.",
                    "last": "Black"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Bridgeman"
                },
                {
                    "first": "Maximillian",
                    "initial": "M.",
                    "last": "Rosario"
                },
                {
                    "first": "Adrian Vs",
                    "initial": "A.V.",
                    "last": "Hill"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Berrie"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Moyle"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Frahm"
                },
                {
                    "first": "Josephine",
                    "initial": "J.",
                    "last": "Cox"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Jill",
                    "initial": "J.",
                    "last": "Gilmour"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "McMichael"
                },
                {
                    "first": "Lucy",
                    "initial": "L.",
                    "last": "Dorrell"
                },
                {
                    "first": "Tom\u00e1\u0161",
                    "initial": "T.",
                    "last": "Hanke"
                }
            ],
            "doi": "10.1038/mt.2013.248",
            "firstpage": "464",
            "issn": "15250016",
            "lastpage": "475",
            "pmid": "24166483",
            "pub_year": 2014,
            "title": "Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1",
            "volume": "22"
        },
        "bib0295": {
            "authors": [
                {
                    "first": "Dan H.",
                    "initial": "D.H.",
                    "last": "Barouch"
                },
                {
                    "first": "Kathryn E.",
                    "initial": "K.E.",
                    "last": "Stephenson"
                },
                {
                    "first": "Erica N.",
                    "initial": "E.N.",
                    "last": "Borducchi"
                },
                {
                    "first": "Kaitlin",
                    "initial": "K.",
                    "last": "Smith"
                },
                {
                    "first": "Kelly",
                    "initial": "K.",
                    "last": "Stanley"
                },
                {
                    "first": "Anna G.",
                    "initial": "A.G.",
                    "last": "McNally"
                },
                {
                    "first": "Jinyan",
                    "initial": "J.",
                    "last": "Liu"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Abbink"
                },
                {
                    "first": "Lori F.",
                    "initial": "L.F.",
                    "last": "Maxfield"
                },
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Seaman"
                },
                {
                    "first": "Anne Sophie",
                    "initial": "A.S.",
                    "last": "Dugast"
                },
                {
                    "first": "Galit",
                    "initial": "G.",
                    "last": "Alter"
                },
                {
                    "first": "Melissa",
                    "initial": "M.",
                    "last": "Ferguson"
                },
                {
                    "first": "Wenjun",
                    "initial": "W.",
                    "last": "Li"
                },
                {
                    "first": "Patricia L.",
                    "initial": "P.L.",
                    "last": "Earl"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Moss"
                },
                {
                    "first": "Elena E.",
                    "initial": "E.E.",
                    "last": "Giorgi"
                },
                {
                    "first": "James J.",
                    "initial": "J.J.",
                    "last": "Szinger"
                },
                {
                    "first": "Leigh Anne",
                    "initial": "L.A.",
                    "last": "Eller"
                },
                {
                    "first": "Erik A.",
                    "initial": "E.A.",
                    "last": "Billings"
                },
                {
                    "first": "Mangala",
                    "initial": "M.",
                    "last": "Rao"
                },
                {
                    "first": "Sodsai",
                    "initial": "S.",
                    "last": "Tovanabutra"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Sanders-Buell"
                },
                {
                    "first": "Mo",
                    "initial": "M.",
                    "last": "Weijtens"
                },
                {
                    "first": "Maria G.",
                    "initial": "M.G.",
                    "last": "Pau"
                },
                {
                    "first": "Hanneke",
                    "initial": "H.",
                    "last": "Schuitemaker"
                },
                {
                    "first": "Merlin L.",
                    "initial": "M.L.",
                    "last": "Robb"
                },
                {
                    "first": "Jerome H.",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "Bette T.",
                    "initial": "B.T.",
                    "last": "Korber"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                }
            ],
            "doi": "10.1016/j.cell.2013.09.061",
            "firstpage": "531",
            "issn": "00928674",
            "pub_year": 2013,
            "title": "XProtective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys",
            "volume": "155"
        },
        "bib0300": {
            "authors": [
                {
                    "first": "Quentin J.",
                    "initial": "Q.J.",
                    "last": "Sattentau"
                }
            ],
            "doi": "10.1097/COH.0000000000000054",
            "firstpage": "217",
            "issn": "1746630X",
            "lastpage": "223",
            "pmid": "24675068",
            "pub_year": 2014,
            "title": "Immunogen design to focus the B-cell repertoire",
            "volume": "9"
        },
        "bib0305": {
            "authors": [
                {
                    "first": "Joseph G.",
                    "initial": "J.G.",
                    "last": "Jardine"
                },
                {
                    "first": "Takayuki",
                    "initial": "T.",
                    "last": "Ota"
                },
                {
                    "first": "Devin",
                    "initial": "D.",
                    "last": "Sok"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "Pauthner"
                },
                {
                    "first": "Daniel W.",
                    "initial": "D.W.",
                    "last": "Kulp"
                },
                {
                    "first": "Oleksandr",
                    "initial": "O.",
                    "last": "Kalyuzhniy"
                },
                {
                    "first": "Patrick D.",
                    "initial": "P.D.",
                    "last": "Skog"
                },
                {
                    "first": "Theresa C.",
                    "initial": "T.C.",
                    "last": "Thinnes"
                },
                {
                    "first": "Deepika",
                    "initial": "D.",
                    "last": "Bhullar"
                },
                {
                    "first": "Bryan",
                    "initial": "B.",
                    "last": "Briney"
                },
                {
                    "first": "Sergey",
                    "initial": "S.",
                    "last": "Menis"
                },
                {
                    "first": "Meaghan",
                    "initial": "M.",
                    "last": "Jones"
                },
                {
                    "first": "Mike",
                    "initial": "M.",
                    "last": "Kubitz"
                },
                {
                    "first": "Skye",
                    "initial": "S.",
                    "last": "Spencer"
                },
                {
                    "first": "Yumiko",
                    "initial": "Y.",
                    "last": "Adachi"
                },
                {
                    "first": "Dennis R.",
                    "initial": "D.R.",
                    "last": "Burton"
                },
                {
                    "first": "William R.",
                    "initial": "W.R.",
                    "last": "Schief"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Nemazee"
                }
            ],
            "doi": "10.1126/science.aac5894",
            "firstpage": "156",
            "issn": "00368075",
            "lastpage": "161",
            "pmid": "26089355",
            "pub_year": 2015,
            "title": "Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen",
            "volume": "349"
        },
        "bib0310": {
            "authors": [
                {
                    "first": "Marina",
                    "initial": "M.",
                    "last": "Caskey"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Klein"
                },
                {
                    "first": "Julio C.C.",
                    "initial": "J.C.C.",
                    "last": "Lorenzi"
                },
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Seaman"
                },
                {
                    "first": "Anthony P.",
                    "initial": "A.P.",
                    "last": "West"
                },
                {
                    "first": "Noreen",
                    "initial": "N.",
                    "last": "Buckley"
                },
                {
                    "first": "Gisela",
                    "initial": "G.",
                    "last": "Kremer"
                },
                {
                    "first": "Lilian",
                    "initial": "L.",
                    "last": "Nogueira"
                },
                {
                    "first": "Malte",
                    "initial": "M.",
                    "last": "Braunschweig"
                },
                {
                    "first": "Johannes F.",
                    "initial": "J.F.",
                    "last": "Scheid"
                },
                {
                    "first": "Joshua A.",
                    "initial": "J.A.",
                    "last": "Horwitz"
                },
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Shimeliovich"
                },
                {
                    "first": "Sivan",
                    "initial": "S.",
                    "last": "Ben-Avraham"
                },
                {
                    "first": "Maggi",
                    "initial": "M.",
                    "last": "Witmer-Pack"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Platten"
                },
                {
                    "first": "Clara",
                    "initial": "C.",
                    "last": "Lehmann"
                },
                {
                    "first": "Leah A.",
                    "initial": "L.A.",
                    "last": "Burke"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Hawthorne"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Gorelick"
                },
                {
                    "first": "Bruce D.",
                    "initial": "B.D.",
                    "last": "Walker"
                },
                {
                    "first": "Tibor",
                    "initial": "T.",
                    "last": "Keler"
                },
                {
                    "first": "Roy M.",
                    "initial": "R.M.",
                    "last": "Gulick"
                },
                {
                    "first": "Gerd",
                    "initial": "G.",
                    "last": "F\u00e4tkenheuer"
                },
                {
                    "first": "Sarah J.",
                    "initial": "S.J.",
                    "last": "Schlesinger"
                },
                {
                    "first": "Michel C.",
                    "initial": "M.C.",
                    "last": "Nussenzweig"
                }
            ],
            "doi": "10.1038/nature14411",
            "firstpage": "487",
            "issn": "00280836",
            "lastpage": "491",
            "pmid": "25855300",
            "pub_year": 2015,
            "title": "Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117",
            "volume": "522"
        },
        "bib0315": {
            "authors": [
                {
                    "first": "Bruce C.",
                    "initial": "B.C.",
                    "last": "Schnepp"
                },
                {
                    "first": "Philip R.",
                    "initial": "P.R.",
                    "last": "Johnson"
                }
            ],
            "doi": "10.1097/COH.0000000000000056",
            "firstpage": "250",
            "issn": "1746630X",
            "lastpage": "256",
            "pmid": "24638019",
            "pub_year": 2014,
            "title": "Adeno-associated virus delivery of broadly neutralizing antibodies",
            "volume": "9"
        },
        "bib0320": {
            "authors": [
                {
                    "first": "Don",
                    "initial": "D.",
                    "last": "Forthal"
                },
                {
                    "first": "Thomas J.",
                    "initial": "T.J.",
                    "last": "Hope"
                },
                {
                    "first": "Galit",
                    "initial": "G.",
                    "last": "Alter"
                }
            ],
            "doi": "10.1097/COH.0b013e328363d486",
            "firstpage": "393",
            "issn": "1746630X",
            "lastpage": "401",
            "pub_year": 2013,
            "title": "New paradigms for functional HIV-specific nonneutralizing antibodies",
            "volume": "8"
        },
        "bib0325": null,
        "bib0330": null
    },
    "body_text": [
        {
            "endOffset": 33855,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Since the HIV vaccine field likely will not see data emerging from the next set of efficacy trials until 2019\u20132020, current strategies are focused on advancing leading candidates through clinical development, improving vaccine delivery methods and optimizing the next generation of candidates entering clinical development.",
            "startOffset": 33532,
            "title": "Status"
        },
        {
            "endOffset": 28997,
            "parents": [],
            "secId": "sec0020",
            "sentence": "To best predict correlates of vaccine efficacy in the absence of additional successful Phase III trials, we must turn to examples of virus control in HIV infected humans and protection from infection or disease in SIV or SHIV models.",
            "startOffset": 28764,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 36607,
            "parents": [],
            "secId": "sec0030",
            "sentence": "Funding over the last several years has flat-lined, and is increasingly vulnerable due to its dependency on just two major sources: 84% of funding comes from the US government and the Bill and Melinda Gates Foundation.",
            "startOffset": 36389,
            "title": "Financing the development of an HIV vaccine"
        },
        {
            "endOffset": 33532,
            "parents": [],
            "refoffsets": {
                "bib0320": {
                    "endOffset": 33531,
                    "startOffset": 33527
                }
            },
            "secId": "sec0025",
            "sentence": "Finally, since the RV-144 trial showed that HIV acquisition could be prevented without bNAbs or robust CD8+ cellular immune responses, studies are ongoing to develop vaccines that elicit antibodies that work through other effector mechanisms, such as Fc-mediated interactions with the innate immune system [31].",
            "startOffset": 33221,
            "title": "Status"
        },
        {
            "endOffset": 25586,
            "parents": [],
            "refoffsets": {
                "bib0245": {
                    "endOffset": 25502,
                    "startOffset": 25498
                },
                "bib0250": {
                    "endOffset": 25585,
                    "startOffset": 25581
                }
            },
            "secId": "sec0015",
            "sentence": "Some two hundred HIV vaccine candidates/regimens have been clinically tested since 1986, yet efficacy trials were completed for only four vaccines [16], only one of which demonstrated modest efficacy in preventing HIV acquisition [17].",
            "startOffset": 25351,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 27528,
            "parents": [],
            "secId": "sec0020",
            "sentence": "The primary HIV animal challenge models include Rhesus macaques challenged with either SIV or a chimeric construct of SIV and HIV Env (SHIV).",
            "startOffset": 27387,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 26793,
            "parents": [],
            "secId": "sec0015",
            "sentence": "Once a safe and effective HIV vaccine is developed and licensed, decisions will have to be made regarding which populations to target for vaccination.",
            "startOffset": 26643,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 26931,
            "parents": [],
            "secId": "sec0015",
            "sentence": "There is general consensus that priority should be given to high risk groups exposed to HIV through sexual contact or injection drug use.",
            "startOffset": 26794,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 32914,
            "parents": [],
            "refoffsets": {
                "bib0305": {
                    "endOffset": 32913,
                    "startOffset": 32909
                }
            },
            "secId": "sec0025",
            "sentence": "Designing immunogens to elicit these bNAbs remains a major challenge, however, though structural design is now beginning to yield more stable and potent immunogens [28].",
            "startOffset": 32745,
            "title": "Status"
        },
        {
            "endOffset": 24809,
            "parents": [],
            "refoffsets": {
                "bib0230": {
                    "endOffset": 24808,
                    "startOffset": 24804
                }
            },
            "secId": "sec0010",
            "sentence": "Therapeutic vaccines for HIV have been evaluated in the past with very limited and inconsistent success, when the model was vaccination during untreated HIV infection [13].",
            "startOffset": 24637,
            "title": "Biological feasibility for therapeutic vaccine development"
        },
        {
            "endOffset": 33870,
            "parents": [],
            "secId": "sec0025",
            "sentence": "These include:",
            "startOffset": 33856,
            "title": "Status"
        },
        {
            "endOffset": 23708,
            "parents": [],
            "secId": "sec0005",
            "sentence": "These studies are providing clues toward understanding how best to elicit cellular immune responses that will control and possibly abort HIV infection.",
            "startOffset": 23557,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 27740,
            "parents": [],
            "secId": "sec0020",
            "sentence": "The SIV or SHIV models are most often chosen based on the availability of appropriate reagents (HIV vaccine candidates made in an SIV version or a SHIV constructed to match the Env in the HIV vaccine candidate).",
            "startOffset": 27529,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 29136,
            "parents": [],
            "refoffsets": {
                "bib0210": {
                    "endOffset": 29135,
                    "startOffset": 29129
                },
                "bib0275": {
                    "endOffset": 29135,
                    "startOffset": 29129
                }
            },
            "secId": "sec0020",
            "sentence": "In humans, CD8+ T cells, particularly those directed at conserved regions of Gag, are correlated with control of virus replication [9,22].",
            "startOffset": 28998,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 30303,
            "parents": [],
            "secId": "sec0020",
            "sentence": "As other proven non-vaccine prevention methods, such as treatment-as-prevention, voluntary medical male circumcision and pre-exposure prophylaxis with antiretroviral drugs become more widely available, it will be more difficult to find appropriate at-risk individuals for vaccine trials, and questions may be raised about the standard of preventive interventions that is required in these trials.",
            "startOffset": 29907,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 37468,
            "parents": [],
            "refoffsets": {
                "bib0330": {
                    "endOffset": 37467,
                    "startOffset": 37463
                }
            },
            "secId": "sec0030",
            "sentence": "Modeling studies indicate that a preventive HIV vaccine could dramatically reduce the number of new infections even if coverage is less than 50% in low- and middle-income countries [33].",
            "startOffset": 37282,
            "title": "Financing the development of an HIV vaccine"
        },
        {
            "endOffset": 31215,
            "parents": [],
            "secId": "sec0025",
            "sentence": "If vaccine efficacy of >50% is demonstrated, a licensure application in South Africa is possible as early as 2021.",
            "startOffset": 31101,
            "title": "Status"
        },
        {
            "endOffset": 37687,
            "parents": [],
            "secId": "sec0030",
            "sentence": "A preventive vaccine could be especially beneficial for people who are unable to access or consistency use current methods for preventing HIV infection, due to barriers or dependency on compliance or behavioral change.",
            "startOffset": 37469,
            "title": "Financing the development of an HIV vaccine"
        },
        {
            "endOffset": 37063,
            "parents": [],
            "secId": "sec0030",
            "sentence": "For HIV vaccines that ultimately reach the state of licensure, initiatives such as The Vaccine Alliance GAVI can help to ensure broad roll-out and access in countries and populations most affected by HIV/AIDS.",
            "startOffset": 36854,
            "title": "Financing the development of an HIV vaccine"
        },
        {
            "endOffset": 32328,
            "parents": [],
            "refoffsets": {
                "bib0290": {
                    "endOffset": 31962,
                    "startOffset": 31958
                },
                "bib0295": {
                    "endOffset": 32327,
                    "startOffset": 32323
                }
            },
            "secId": "sec0025",
            "sentence": "One focuses immune responses to those regions of HIV that are highly conserved and therefore may be required for viral replicative fitness (Oxford University, IAVI, EDCTP) [25], while the other, termed \u201cmosaic antigens\u201d use in silico methods (Los Alamos National Laboratories) to design immunogens that represent diverse sequences representing the optimal choice of epitopes from all known HIV strains, for broad coverage of circulating viruses (Johnson and Johnson/Janssen, Beth Israel Deaconess Medical Center, NIAID, Ragon Institute) [26].",
            "startOffset": 31786,
            "title": "Status"
        },
        {
            "endOffset": 34411,
            "parents": [],
            "secId": "sec0025",
            "sentence": "HIV Antibody Epitope Based Vaccines: Recent elucidation of at least five major epitopes on HIV Env that bind bNAbs will lead to the generation of clinical candidates targeting each of these epitopes, including glycopeptides (see also below), computationally derived scaffolds and novel immunogens designed to bind to putative germline ancestors of the bNAbs.",
            "startOffset": 34053,
            "title": "Status"
        },
        {
            "endOffset": 29590,
            "parents": [],
            "secId": "sec0020",
            "sentence": "Whether these unconventional responses will also be effective in controlling HIV in humans remains to be seen.",
            "startOffset": 29480,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 36388,
            "parents": [],
            "secId": "sec0030",
            "sentence": "In 2014, 841 million USD was available, invested in basic research (29%), preclinical research (33%), clinical research (34%), and other (4%).",
            "startOffset": 36246,
            "title": "Financing the development of an HIV vaccine"
        },
        {
            "endOffset": 22627,
            "parents": [],
            "secId": "sec0005",
            "sentence": "While some individuals remain uninfected despite multiple exposures to HIV-1, immune-mediated correlates of protection have not been conclusively identified.",
            "startOffset": 22470,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 24159,
            "parents": [],
            "secId": "sec0005",
            "sentence": "A number of broadly neutralizing human monoclonal antibodies (bNAbs) have been isolated and characterized in detail.",
            "startOffset": 24043,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 24456,
            "parents": [],
            "refoffsets": {
                "bib0225": {
                    "endOffset": 24455,
                    "startOffset": 24451
                }
            },
            "secId": "sec0005",
            "sentence": "In animal models, passive transfer of several different bNAbs can prevent infection at antibody concentrations that should be achievable by vaccination [12].",
            "startOffset": 24299,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 31785,
            "parents": [],
            "secId": "sec0025",
            "sentence": "For example, vaccines based on two different hypotheses to elicit broad cellular immune responses are in development.",
            "startOffset": 31668,
            "title": "Status"
        },
        {
            "endOffset": 35777,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Synthetic Biology Technologies: Novel DNA and RNA vaccines are being explored in efforts to achieve the efficacy of viral vectors while mitigating concerns of anti-vector immunity.",
            "startOffset": 35597,
            "title": "Status"
        },
        {
            "endOffset": 27989,
            "parents": [],
            "secId": "sec0020",
            "sentence": "SHIV constructs, however, are generally less virulent and are more easily neutralized by antibodies to HIV Env.",
            "startOffset": 27878,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 31100,
            "parents": [],
            "secId": "sec0025",
            "sentence": "These trials may add additional booster immunizations and more potent adjuvants aimed at extending the durability of protection.",
            "startOffset": 30972,
            "title": "Status"
        },
        {
            "endOffset": 23264,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The contribution of cellular immunity to controlling infection has also been observed in simian immunodeficiency virus (SIV) challenge studies of rhesus macaques, although the correlates of protection are not well understood.",
            "startOffset": 23039,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 36137,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Glycobiology: Advances in glycobiology are yielding important insights for HIV vaccine research, both in characterization and synthesis of targets recognized by bNAbs, and in strategies to manipulate vaccine-induced Fc-mediated immune responses such as ADCVI and ADCC.",
            "startOffset": 35869,
            "title": "Status"
        },
        {
            "endOffset": 35348,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Research in this area will focus on vectors generating persistent infection, mucosal delivery, and targeting of the gut-associated lymphoid tissues all in hope of mimicking the efficacy of a live attenuated vaccine.",
            "startOffset": 35133,
            "title": "Status"
        },
        {
            "endOffset": 37281,
            "parents": [],
            "secId": "sec0030",
            "sentence": "HIV vaccines, notably those with a high level of efficacy and broad coverage (across HIV variants) will likely be very cost-efficient, especially when considered against the cost of life-long antiretroviral treatment.",
            "startOffset": 37064,
            "title": "Financing the development of an HIV vaccine"
        },
        {
            "endOffset": 29479,
            "parents": [],
            "refoffsets": {
                "bib0280": {
                    "endOffset": 29478,
                    "startOffset": 29474
                }
            },
            "secId": "sec0020",
            "sentence": "Interestingly, however, some of the macaques that were protected from SIV challenge after vaccination with CMV vectors expressing multiple SIV antigens contained unconventional T effector cells [23].",
            "startOffset": 29280,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 26320,
            "parents": [],
            "refoffsets": {
                "bib0255": {
                    "endOffset": 26319,
                    "startOffset": 26315
                }
            },
            "secId": "sec0015",
            "sentence": "More recently, a DNA prime boosted with an Ad5 vector delivering gag-pol-nef and three env genes (NIAID Vaccine Research Center) had no effect on HIV infection or viral load in those who became infected [18].",
            "startOffset": 26112,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 27877,
            "parents": [],
            "secId": "sec0020",
            "sentence": "The most common SIV strain used, mac239, is very difficult to neutralize and CD8+ T cells provide limited protection against this virus.",
            "startOffset": 27741,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 24298,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In vitro experiments have shown that combinations of such bNAbs can prevent infection of human CD4+ T cells by virtually all HIV isolates.",
            "startOffset": 24160,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 37850,
            "parents": [],
            "secId": "sec0030",
            "sentence": "The best hope for ending the AIDS pandemic is to develop an effective, accessible vaccine that is delivered in the context of a comprehensive prevention strategy.",
            "startOffset": 37688,
            "title": "Financing the development of an HIV vaccine"
        },
        {
            "endOffset": 26111,
            "parents": [],
            "secId": "sec0015",
            "sentence": "One possibility is that repeated vaccination with the Ad5 vector stimulated a generalized immune activation that then provided activated CD4+ target cells for HIV.",
            "startOffset": 25948,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 31458,
            "parents": [],
            "secId": "sec0025",
            "sentence": "In addition, test of concept efficacy trials are now under consideration for prime-boost regimens utilizing next generation pox vectors (NYVAC; Sanofi), gp120 boosters (Novartis), and DNA (IPPOX Foundation, VICAL) in adaptive clinical trials.",
            "startOffset": 31216,
            "title": "Status"
        },
        {
            "endOffset": 32499,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Recent technological advances in B cell immunology, next generation sequencing, bioinformatics and structural biology have facilitated the generation of many potent bNAbs.",
            "startOffset": 32328,
            "title": "Status"
        },
        {
            "endOffset": 33220,
            "parents": [],
            "refoffsets": {
                "bib0310": {
                    "endOffset": 33079,
                    "startOffset": 33075
                },
                "bib0315": {
                    "endOffset": 33219,
                    "startOffset": 33215
                }
            },
            "secId": "sec0025",
            "sentence": "bNAbs are also being evaluated for passive prophylaxis and treatment, in phase I-II clinical trials (NIH Vaccine Research Center, Rockefeller University, MHRP) [29], and for delivery by gene transfer using adeno-associated virus vectors (Children's Hospital of Philadelphia, IAVI) in a phase I trial [30].",
            "startOffset": 32915,
            "title": "Status"
        },
        {
            "endOffset": 24578,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The activity and specificity of bNAbs is currently guiding the design of immunogens to elicit broad virus neutralization.",
            "startOffset": 24457,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 34697,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Sequential Immunization with Different Immunogens: Increased understanding of how bNAbs evolve along with virus evolution in the human host will lead to testing the hypothesis that sequential immunization with different immunogens may be required to drive antibody affinity maturation.",
            "startOffset": 34412,
            "title": "Status"
        },
        {
            "endOffset": 35512,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Antigen Presentation Systems and Novel Adjuvants: Several virus-like particle and nanoparticle antigen presentation systems and novel adjuvants are in development.",
            "startOffset": 35349,
            "title": "Status"
        },
        {
            "endOffset": 23556,
            "parents": [],
            "refoffsets": {
                "bib0215": {
                    "endOffset": 23555,
                    "startOffset": 23551
                }
            },
            "secId": "sec0005",
            "sentence": "Pre-clinical studies have shown that recombinant cytomegalovirus (CMV) vectored SIV vaccines induce CD8+ effector memory cells\u2014some conventionally restricted by MHC class I and some unconventional cells\u2014that control SIV to undetectable levels in approximately 50% of immunized macaques [10].",
            "startOffset": 23265,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 25947,
            "parents": [],
            "secId": "sec0015",
            "sentence": "An adenovirus type 5 vector with a gag-pol-nef insert (Merck) not only failed to control HIV infection but transiently potentiated HIV acquisition for reasons that remain unclear.",
            "startOffset": 25768,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 34052,
            "parents": [],
            "secId": "sec0025",
            "sentence": "HIV Env Trimers: Recent resolution of the structure of a stabilized HIV Env trimer will lead to clinical evaluation of immunogens more closely mimicking the native Env glycoprotein.",
            "startOffset": 33871,
            "title": "Status"
        },
        {
            "endOffset": 23038,
            "parents": [],
            "refoffsets": {
                "bib0210": {
                    "endOffset": 23037,
                    "startOffset": 23034
                }
            },
            "secId": "sec0005",
            "sentence": "In people who control virus replication and remain well for many years, Gag-specific CD8+ T cells can inhibit HIV-1 replication in ex vivo-infected cells, a phenotype not observed in those who become ill more quickly [9].",
            "startOffset": 22817,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 26643,
            "parents": [],
            "secId": "sec0015",
            "sentence": "The most promising product, a prime-boost regimen of a Canarypox vector delivering gag-pol-env with a gp120 protein boost (ALVAC \u2013 Sanofi; gp120-Vaxgen), designed to elicit both cellular and humoral immunity, demonstrated for the first time that a vaccine could prevent HIV acquisition with 31.2% overall efficacy (RV144).",
            "startOffset": 26321,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 29906,
            "parents": [],
            "secId": "sec0020",
            "sentence": "Phase III HIV vaccine efficacy trials have enrolled a heterogeneous array of populations, including men who have sex with men, injection drug users, heterosexual men and women at high risk for HIV infection, and members of the general population from across global regions in the Americas, South Africa and Thailand.",
            "startOffset": 29590,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 31667,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Parallel efforts are developing vaccine candidates addressing the hyper-variability of HIV, aimed at increasing breadth of antibody and T cell responses or focusing responses to conserved regions of the virus.",
            "startOffset": 31458,
            "title": "Status"
        },
        {
            "endOffset": 27215,
            "parents": [],
            "refoffsets": {
                "bib0260": {
                    "endOffset": 27214,
                    "startOffset": 27207
                },
                "bib0265": {
                    "endOffset": 27214,
                    "startOffset": 27207
                }
            },
            "secId": "sec0015",
            "sentence": "Vaccination of infants has also been proposed and tested in previous early phase clinical studies, however ancillary treatment with drugs or passive antibodies would likely be needed to prevent infection initially, until the child's immune system responds to the vaccination [19,20].",
            "startOffset": 26932,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 34960,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Conserved/Mosaic Hybrids: Next generation immunogens to elicit broad cellular immune responses will take advantage of the attributes of both conserved and mosaic antigens to drive breadth, depth and enhanced coverage of cellular immune responses by immunization.",
            "startOffset": 34698,
            "title": "Status"
        },
        {
            "endOffset": 28190,
            "parents": [],
            "secId": "sec0020",
            "sentence": "For an updated list of the status of candidates in current developement, please see Table 1.",
            "startOffset": 28098,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 27386,
            "parents": [],
            "secId": "sec0020",
            "sentence": "HIV vaccine candidates are advanced on the basis of safety and immunogenicity data from animal models and from Phase I clinical trials.",
            "startOffset": 27251,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 25767,
            "parents": [],
            "secId": "sec0015",
            "sentence": "An Env subunit vaccine (gp120, VaxGen) formulated in an alum adjuvant failed to elicit antibodies that could neutralize most tested isolates or to prevent or control HIV infection.",
            "startOffset": 25587,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 23879,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Despite the importance of eliciting a robust cellular immune response, most effective vaccines prevent infection by stimulating the development of neutralizing antibodies.",
            "startOffset": 23708,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 24042,
            "parents": [],
            "refoffsets": {
                "bib0220": {
                    "endOffset": 24041,
                    "startOffset": 24037
                }
            },
            "secId": "sec0005",
            "sentence": "About 5% of HIV infected individuals develop potent neutralizing antibodies against Env that effectively neutralize a broad range of HIV-1 isolates in vitro [11].",
            "startOffset": 23880,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 30971,
            "parents": [],
            "refoffsets": {
                "bib0285": {
                    "endOffset": 30970,
                    "startOffset": 30966
                }
            },
            "secId": "sec0025",
            "sentence": "As an outcome of the RV-144 efficacy trial, the Pox-Protein Public Private Partnership, consisting of Sanofi, Novartis, NIAID, Bill & Melinda Gates Foundation, the Military HIV Research Program (MHRP) and the HIV Vaccine Clinical Trials Network, is planning a next phase of efficacy trials that may test the RV144 vaccine regimen in a population of men who have sex with men in Thailand and in heterosexual populations in sub-Saharan Africa [24].",
            "startOffset": 30525,
            "title": "Status"
        },
        {
            "endOffset": 36854,
            "parents": [],
            "secId": "sec0030",
            "sentence": "Over the next 5\u201310 years, it will be essential for funding to respond to the global pipeline, notably the planned efficacy studies and efforts to leverage new knowledge, such as in the bNAb domain, to design and evaluate novel vaccine approaches.",
            "startOffset": 36608,
            "title": "Financing the development of an HIV vaccine"
        },
        {
            "endOffset": 25250,
            "parents": [],
            "secId": "sec0010",
            "sentence": "This approach will be hindered by the enormous variation of HIV within each infected person, but might hold promise if vaccines that induce sufficiently broad, potent and durable immune responses were employed.",
            "startOffset": 25040,
            "title": "Biological feasibility for therapeutic vaccine development"
        },
        {
            "endOffset": 28763,
            "parents": [],
            "refoffsets": {
                "bib0270": {
                    "endOffset": 28762,
                    "startOffset": 28758
                }
            },
            "secId": "sec0020",
            "sentence": "For example, efficacy in the RV144 trial was associated with non-neutralizing IgG antibodies to the V1V2 region of Env [21].",
            "startOffset": 28639,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 29279,
            "parents": [],
            "secId": "sec0020",
            "sentence": "The general consensus is that vaccine candidates should induce classical CD8+ T effector or effector memory cells (restricted by Class I MHC).",
            "startOffset": 29137,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 28638,
            "parents": [],
            "secId": "sec0020",
            "sentence": "Although a clear correlate of protection remains elusive, through pre-clinical and clinical evaluation, it is presumed that the best vaccine candidates should elicit neutralizing antibodies, non-neutralizing antibodies that mediate viral clearance through other mechanisms (such as antibody-dependent cell-mediated cytotoxicity-ADCC or virus inhibition, ADCVI), and T cells (primarily CD8+) that suppress virus growth or kill virus-infected cells.",
            "startOffset": 28191,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 35132,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Replication Competent Viral Vectors: Replicating adenovirus, poxvirus, vesiculostomatitis virus and Sendai virus vectors are in preclinical and early clinical development.",
            "startOffset": 34961,
            "title": "Status"
        },
        {
            "endOffset": 25039,
            "parents": [],
            "refoffsets": {
                "bib0235": {
                    "endOffset": 25038,
                    "startOffset": 25031
                },
                "bib0240": {
                    "endOffset": 25038,
                    "startOffset": 25031
                }
            },
            "secId": "sec0010",
            "sentence": "Recently, an alternative approach has been tested, which is to vaccinate patients on highly effective ART, in the hope of preventing virus escape once treatment is stopped or effecting a cure by removing virus reservoirs [14,15].",
            "startOffset": 24810,
            "title": "Biological feasibility for therapeutic vaccine development"
        },
        {
            "endOffset": 35868,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Delivery of such genetic vaccines by electroporation has shown promise in clinical trials.",
            "startOffset": 35778,
            "title": "Status"
        },
        {
            "endOffset": 22469,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Unlike many infectious diseases, HIV infection does not resolve and give rise to protective immunity against subsequent exposure.",
            "startOffset": 22340,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 35596,
            "parents": [],
            "secId": "sec0025",
            "sentence": "They are based on advances in understanding of innate and adaptive immune linkages.",
            "startOffset": 35513,
            "title": "Status"
        },
        {
            "endOffset": 28097,
            "parents": [],
            "refoffsets": {
                "bib0245": {
                    "endOffset": 28096,
                    "startOffset": 28092
                }
            },
            "secId": "sec0020",
            "sentence": "More than 250 HIV vaccine Phase I and II clinical trials have been conducted in more than 30 countries [16].",
            "startOffset": 27989,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 32744,
            "parents": [],
            "refoffsets": {
                "bib0300": {
                    "endOffset": 32743,
                    "startOffset": 32739
                }
            },
            "secId": "sec0025",
            "sentence": "Studies have identified bNAb binding sites on HIV Env, solved structural characterization of Env trimer and Env epitopes with atomic-level precision, and provided a better understanding of the ontogeny of bNAbs in HIV infected individuals [27].",
            "startOffset": 32500,
            "title": "Status"
        },
        {
            "endOffset": 22816,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Adaptive immune responses against HIV are often directed toward the envelope (Env) protein on the surface of the virus and the capsid protein (Gag) that surrounds and protects the HIV RNA.",
            "startOffset": 22628,
            "title": "Biological feasibility for prophylactic vaccine development"
        },
        {
            "endOffset": 36245,
            "parents": [],
            "refoffsets": {
                "bib0325": {
                    "endOffset": 36244,
                    "startOffset": 36240
                }
            },
            "secId": "sec0030",
            "sentence": "HIV vaccine R&D is funded by the public and private sector [32].",
            "startOffset": 36181,
            "title": "Financing the development of an HIV vaccine"
        },
        {
            "endOffset": 30518,
            "parents": [],
            "secId": "sec0020",
            "sentence": "Consultation with involved communities will be essential, as emphasized in UNAIDS Good Participatory Practices Guidelines (http://www.unaids.org/sites/default/files/media_asset/JC1853_GPP_Guidelines_2011_en_0.pdf).",
            "startOffset": 30304,
            "title": "Technical and regulatory assessment"
        }
    ],
    "docId": "S0264410X16002802",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "jsafrit@iavi.org",
                "first": "Jeffrey T.",
                "initial": "J.T.",
                "last": "Safrit"
            },
            {
                "email": null,
                "first": "Patricia E.",
                "initial": "P.E.",
                "last": "Fast"
            },
            {
                "email": null,
                "first": "Lisa",
                "initial": "L.",
                "last": "Gieber"
            },
            {
                "email": null,
                "first": "Hester",
                "initial": "H.",
                "last": "Kuipers"
            },
            {
                "email": null,
                "first": "Hansi J.",
                "initial": "H.J.",
                "last": "Dean"
            },
            {
                "email": null,
                "first": "Wayne C.",
                "initial": "W.C.",
                "last": "Koff"
            }
        ],
        "doi": "10.1016/j.vaccine.2016.02.074",
        "firstpage": "2921",
        "issn": "0264410X",
        "keywords": [
            "AIDS",
            "HIV",
            "Prevention",
            "Vaccines"
        ],
        "lastpage": "2925",
        "openaccess": "Full",
        "pub_year": 2016,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Status of vaccine research and development of vaccines for HIV-1"
    }
}